BREAST CANCER BASE

Although mammography screening camera Europe and the United States in some countries has been used, but there has been controversy. Cochrane Breast Cancer Research recently published a pair of seven mammographic screening of breast cancer randomized controlled study of the meta-analysis data, mammographic screening of breast cancer pros and cons of the controversy become fiercer. At the recently held this year's ASCO annual meeting, the oncologists, the Commission of Jurists <BR> dollars and breast cancer associated with the number of scholars from the fields on this meta-analysis presented their interpretations and viewpoints.

According to a new Boston University Medicine and School of Public Health researchers preliminary study found that green tea may help women prevent breast cancer.

Gaiersangsaishen professor from the leadership of the research team selected a long breast tumor rats as subjects. Scientists mice were divided into two groups, one group was fed green tea, another group fed only ordinary water. The results showed that a group of tea mice tumor is shrinking.

Recently in Beijing at the 2003 new breast cancer treatment at the seminar, from the United States BaylorSammons breast cancer experts in the center released by the Center for metastatic breast cancer in combination with chemotherapy in patients with the latest research findings.

The study of 529 untreated metastatic breast cancer patients, before the transfer have received anthracycline-based drug treatment. The study will be divided into two groups in all cases, a group of 267 patients who received Gemzar / Taxol combination with chemotherapy for a 21-day cycle; The remaining patients to accept another group of single-drug paclitaxel chemotherapy, treatment continued until disease progression or the emergence of tolerance of side effects. The results showed that combination chemotherapy group that the median time to progression was 5.4 months, Taxol alone group to 3.5 months. In addition, the United chemotherapy group over 50% of patients without disease progression time is six months.

Journal of Clinical Oncology, the study, a diameter of less than 1 cm breast lumps acceptable postoperative radiotherapy combined, if a tumor estrogen receptor-positive, a further tamoxifen treatment.

The University of Pittsburgh School of Medicine said Dr. Bernard Fisher, the study seeks to clarify the tumor resection and postoperative radiotherapy in the treatment program right without lymph node metastasis, the diameter of less than 1 cm in invasive breast cancer treatment, but it envisaged the prevention of tamoxifen treatment of breast cancer recurrence after radiotherapy than simply more effective, if and postoperative radiotherapy combined use will play better results.